SARS-CoV-2 Nucleocapsid Antikörper
Kurzübersicht für SARS-CoV-2 Nucleocapsid Antikörper (ABIN6990049)
Target
Alle SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Greater than 95% as determined by reducing SDS-PAGE.
-
Immunogen
- Nucleocapsid recombinant protein
-
-
-
-
Applikationshinweise
- ELISA: 1:160000, WB: 1:2000~3000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 10 % glycerol, pH 7.2
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,4 °C
-
Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
-
-
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
Andere Bezeichnung
- SARS-CoV-2 Nucleocapsid
-
Substanzklasse
- Viral Protein
-
Hintergrund
- Fully humanized monoclonal antibody paired with human monoclonal antibody LOCUS:QHD43423 419aa linear VRL 18-MAR-2020 DEFINITION:nucleocapsid phosphoprotein [Severe acute respiratory syndrome coronavirus 2]. ACCESSION:QHD43423 VERSION:QHD43423.2 DBSOURCE:accession MN908947.3 SOURCE:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ORGANISM:Viruses, Riboviria, Nidovirales, Cornidovirineae, Coronaviridae,Orthocoronavirinae, Betacoronavirus, Sarbecovirus.
-
Gen-ID
- 43740575
Target
-